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Introduction
Esophageal adenocarcinoma is one of the most 
common malignancies in the world with a very poor 
prognosis. EAC ranked as the sixth leading cause of 
cancer death in the world (Parkin et al., 2001). In 2012, 
it is estimated that 455,800 esophageal cancer cases 
and 400,200 deaths are occurred in the word. Based on 
selected registries, the highest esophageal cancer incidence 
rates are in Malawi, South Africa, and Iran (Torre et al., 
2016). The incidence of esophageal adenocarcinoma 
has been increased dramatically over the past 25 years 
(Brown and Devesa, 2002) and it perhaps represents a 
true rise in disease burden (Pohl and Welch, 2005). It 
has been reported the rapid increament in the incidence 
of EAC among white men (Brown et al., 2008). EAC is 
the sixth most common cancer among males and ninth 
most common cancer among females globally (Guo and 
Jiang, 2009). Henan province of northern china has the 
highest incidence and mortality of EAC in the world 
(Ke, 2002). The majority of EAC patients present with 
advanced metastatic disease upon diagnosis (Rubenstein 
and Shaheen, 2015). It is important to understand the 
molecular mechanism in the tumor invasion process to 
assist finding new biomarkers for early diagnosis and 
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prognostic evaluation (Fu et al., 2007). There has been 
a lack of systematic analysis of the molecular markers 
that characterize protein of EAC. Attempts to clarify the 
mechanism underlying esophageal cancer by searching 
for novel proteins and proteins interactions are attractive 
recently. Undrestanding a network containing proteins, 
and generalized an existing computational methods were 
used to identify related disease proteins simultaneously 
(Gao et al., 2015). PPI network analysis as an attracting 
method is used for molecular assesment of many diseases 
(Shannon et al., 2003; Massoud and Gambhir, 2007). 
In this method, many proteins implicated to a certain 
disease reterived and atribute in an interactive structure 
(PPI network) (Liu et al., 2014; Safari-Alighiarloo et al., 
2014; Abbaszadeh et al., 2017). Topological analysis of 
network provide useful information about roles of the 
initial proteins (nodes) in the nework (Safari-Alighiarloo 
et al., 2014; Moreau and Tranchevent, 2012; Safari-
Alighiarloo et al., 2016). Crucial nodes of network are 
the important proteins related to the studied disease 
(Safari-Alighiarloo et al., 2016; Zamanian-Azodi et al., 
2015). These key proteins interact with the large numbers 
of the nodes of network and considerable types of their 
connections are as shortest lengh paths so they are called 
hub-bottleneck proteins (Goh et al., 2007; Safaei et al., 
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2016). Gene ontology analysis can be used to determine 
underlying biological processes, molecular function, 
cellular component and biochemical pathways relative to 
the proteins. These findings can be used in interpretation 
of played roles of the proteins in onset and development of 
any diseases (Goh et al., 2007; Barabási et al., 2011; Özgür 
et al, 2008; Safaei et al., 2016). In this study, we aimed 
to clarify protein-protein interactions of EAC by network 
analysis. It can lead to purpose a panel of informative 
biomarkers specific to esophageal adenocarcinoma.
Materials and Methods
Since the significant proteins related to a certain 
disease are selected and collected in the string data base 
and this data bank is up dated periodically, a number of 200 
possible proteins correlated to esophageal adenocarcinoma 
were retrived from disease query of STRING DB V 10.5 
(http://string-db.org/) (Coates, 2015). This database is one 
of the Cytoscape software 3.4.0 applications (Tian et al., 
2017) that provides interaction information from three 
different panels including disease query, protein query, 
and PubMed query. The strenght of protein interactions 
can be fitted for the network construction (Szklarczyk et 
al., 2016). Here, it is set as the 0.4, the default option. 
The proteins were analyzed via the undirected edges 
methods by Cytoscape software. The main connected 
component of PPI network was layout by degree values. 
Power law is a line that correlates the number of the nodes 
as a function of degree values. The suitable fitted power 
law is corresponded to scale free network (Barabási and 
Bonabeau, 2003). The constructed network was scale 
free network. The top 10% of the nodes based on degree 
value were selected as hub nodes. Degree, betweenness, 
closeness, stress distributions were provided for more 
screening of the introduced hub nodes due to identify 
potent hub genes. However grouping of the hub nodes is 
leaded to detemine super hub nodes and the other potent 
hub genes (the top potent hub nodes are introduced as 
super hub genes). The main connected component (the 
network) was analyzed by Cluster ONE V.1.0. (clustering 
with overlapping neighborhood expansion), the other 
application of Cytoscape software (Saito et al., 2012) 
that found one significant cluster. In fact, this plug-in 
derives densely interconnected reigons in the PPI network. 
Presence of at least 10 proteins in the cluster and P-value 
less than 0.05 were used to identify significant cluster. 
Furthermore, the obtained cluster as a sub-network 
was analyzed and the contributing nodes were classified 
regarding degree values. The top hub proteins of cluster 
and the main connected component were compared and 
the major candidated biomarker panel was introduced. The 
connections of the proteins of panel were illustrited. The 
elements of the cluster were assested by ClueGO (Bindea 
et al., 2009) for enrichment analysis. The statistical criteria 
for this examination (pathway analysis) are as follow: 
Kappa score (term/pathway connectivity) = 0.2. Gene 
per term was set to 5 and the percentage of atributing 
proteins was set to 3. P-Value correction method was 
Bonferroni step down (Bindea et al., 2009; Bindea et al., 
2013). P-value less than 0.05 was considered as significant 
parameter in all steps of analysis.
Results
A number of 200 possible related proteins for 
esophageal adenocarcinoma were searched via STRING 
database but only 182 proteins were found in database and 
included in network study. The protein-protein interaction 
network of disease was constructed with 182 proteins. The 
number of 50 nodes were isolated and one component of 
three connected nodes were formed. The main connected 
component including 129 nodes and 562 edges was 
constructed (see Figure 1). As it shown in Figure 1 each 
node is distinguishable from the other nodes based on 
degree value. The network was analyzed and the nodes 
R name Description D BC CC S DS ASPL 
1 TP53 tumor protein p53 58 0.26 0.6 15192 1.83 1.67
2 EGFR epidermal growth factor receptor 45 0.12 0.55 9250 1.21 1.83
3 AKT1 v-akt murine thymoma viral oncogene homolog 1 43 0.1 0.53 7606 0.84 1.88
4 ERBB2 v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, 
neuro/glioblastoma derived oncogene homolog (avian)
39 0.06 0.52 5894 1.55 1.91
5 MYC v-myc myelocytomatosis viral oncogene homolog (avian) 35 0.08 0.51 5902 1.27 1.95
6 CCND1 cyclin D1 35 0.06 0.52 5630 1.14 1.92
7 CTNNB1 catenin (cadherin-associated protein), beta 1, 88kDa 34 0.07 0.53 5986 1.04 1.89
8 CDH1 cadherin 1, type 1, E-cadherin (epithelial) 29 0.06 0.51 4596 1.04 1.96
9 BCL2L1 BCL2-like 1 23 0.03 0.47 2464 0.69 2.11
10 WWOX WW domain containing oxidoreductase 22 0.06 0.46 4504 1.32 2.16
11 FOXM1 forkhead box M1 21 0.05 0.46 4318 0.78 2.16
12 CDKN2A cyclin-dependent kinase inhibitor 2A 21 0.01 0.47 1082 1.37 2.12
13 RAC1 ras-related C3 botulinum toxin substrate 1 (rho family, small 
GTP binding protein Rac1)
18 0.04 0.46 2826 0.71 2.17
Table 1. The Top 10% of the Nodes (Including 13 Proteins ) Based on Degree Value were Selected as Hub Nodes. 
The top eight genes are introdued as related biomarkers to EAC. D, BC, CC, S, DS and ASPL correspond to degree, 
betweenness centrality, closeness centrality, stress, disease score and average shortest paths length respectively. 
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shown in Figure 4. Distribution of the nodes of cluster-1 
sub-network versus the ranges of degree value is shown 
in Figuer 5. Based on this distribution, the top 10 nodes 
of this sub-network were selected as the hub nodes of 
the analyzed cluster (see Tabel 2). As it is depicted in the 
Table 3, there are nine common genes between Tables 1 
and 2. The closed relationship between the nine key genes 
is presented in the Figure 6. Gene ontology is a powerful 
method for assessment of biological pathways, molecular 
function, biological processes and cellular component 
related to the set of proteins (Thomas et al., 2003; Vastrik 
et al., 2007). Since cluster-1 includes all key proteins of 
the main network, gene ontology analysis of 27 proteins 
were sorted by degree value. The top 10% of the nodes 
(including 13 proteins ) were selected as hub nodes. 
The characteristic properties of the hub nodes based on 
analysis of the network are tabulated in Table 1. These 
properties are including degree, betweenness, closeness, 
stress, disease score and average shortest paths length 
(ASPL). Distribution of the nodes centralities is a 
useful tool for determination of the potent key nodes 
and also property of the network (Flórez et al., 2010). 
This distriution for degree, betweenness and closeness 
is shown in the Figure 2. These informative graphs are 
used to determine suitable cut off to identify the crucial 
nodes (Yu et al., 2007; Aittokallio and Schwikowski, 
2006). Grouping of found data is useful tool to screen 
and classify them. The classified 13 hub nodes based 
on degree value in four groups is shown in Figure 3. 
Since clustering provides important information relative 
to the some crucial parts of a network (Berkhin, 2006), 
two clusters restricted by presence at least 10 nodes 
were identified, however only one of them is valided by 
statistical test. The sub-network related to this cluster is 
Figure 1. Main Connected Component of protein-protein 
interaction network of esophageal adenocarcinoma. 
The component includes 129 nodes and 562 edges. 
The network is layout by degree value of the nodes. 
The bigger size of node corresponds to higher value of 
degree. The color change from orange to blue indicates 
increment of degree value.
R Name description D BC CC S DS
1 TP53 tumor protein p53 24 0.08 0.93 260 1.83
2 EGFR epidermal growth factor receptor 24 0.1 0.93 276 1.21
3 MYC v-myc myelocytomatosis viral oncogene homolog (avian) 23 0.07 0.9 230 1.27
4 AKT1 v-akt murine thymoma viral oncogene homolog 1 23 0.05 0.9 218 0.84
5 ERBB2 v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/
glioblastoma derived oncogene homolog (avian)
23 0.1 0.9 252 1.55
6 CCND1 cyclin D1 21 0.04 0.84 166 1.14
7 CTNNB1 catenin (cadherin-associated protein), beta 1, 88kDa 19 0.02 0.79 114 1.04
8 BCL2L1 BCL2-like 1 18 0.03 0.76 100 0.69
9 CDKN2A cyclin-dependent kinase inhibitor 2A 17 0.01 0.74 72 1.37
10 CDH1 cadherin 1, type 1, E-cadherin (epithelial) 16 0.01 0.72 52 1.04
Table 2. Top 10 hub nodes of the Cluster-1. The Properties of the Nodes are Determined
Figure 2. up) Distribution of the Nodes versus Degree, 
middle) Betweenness Centrality versus Number 
of Neighbors for the Nodes, and down) Closeness 
Centrality versus Number of Neighbors for the Nodes 
are Illustrated. The power law is drowning in red color. 
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of this cluster is performed by ClueGO application of 
Cytoscape. The results are shown in Figures 7-8.
Discussion 
Protein molecules play a major role in different 
diseases and stress condition that their expression 
contributes to the onset and advances of diseases (Lamb 
et al., 2006; Zamanian–Azodi et al., 2016). These related 
proteins to a certain type of disease or condition are 
present in a whole interacting system (PPI), that worth 
further analysis for interpreting centrality roles (Fraser 
et al., 2002; Khayyer et al., 2017). In a way that, the 
associated proteins are screened and ranked in this manner 
and finally among many initial proteins a few proteins 
will be presented as highlighted proteins (Rual et al., 
2005). These key proteins can be potentially differential 
biomarkers. In this investigation, 200 proteins related 
to esophagus adenocarcinoma from STRING DB were 
retrieved; however, only 182 proteins were extracted. 
At last, the constructed PPI network of EAC was by 182 
proteins. The network contains 50 isolated proteins, a 
triple connected nodes and a main connected component. 
The main component contains 129 nodes and 562 edges 
(see Figure 1). In this component (network), the nodes are 
distincted based on the role of the nodes in the network. 
This role is depended to the central properties of the 
nodes in the network. Degree, betweenness, closeness 
and stress are four important central parameters in the 
network analysis. 
The network was analyzed and central parameters 
of the nodes were determined. These parameters were 
Gene TP53 EGFR AKT1 ERBB2 MYC CCND1 CTNNB1 CDH1 BCL2L1
Row in Table 1 1 2 3 4 5 6 7 8 9
Row in Table 2 1 2 4 5 3 6 7 10 8
Table 3. The Top Nodes in Table 1 that are Presented in the Table 2 are shown
Figure 3. Classification of 13 Hub Nodes Based of 
Degree Value
Figure 4. The Sub- Network Corresponds to the 
Significant Cluster. The sub-network includes 27 nodes 
and 179 edges. This cluster was determined by cluster 
ONE application of Cystoscape software. The cluster 
identification was restricted by presence of at least 10 
nodes in cluster (p<0.001).
Figure 5. Distribution of the Nodes of Cluster-1 
Sub-Network versus the Ranges of Degree Value is 
Presented
Figure 6. Final Candidate Biomarker Panel Related to 
Esophageal Adenocarcinoma Including Proteins and 
Their Interactions. The size and color of the nodes are 
layout by degree value. The bigger size and highlighted 
color is corresponded to higher value of degree. All of 
the nodes are connected to each other.
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sorted based on degree value and the top10% of the 
nodes (including 13 nodes) were selected as hub nodes 
and tabulated in Table 1. Typically, limited number of 
proteins can be considered as a suggestive panel for a 
specific disease. Therefore, it is tried to restrict the number 
of the hub nodes. As it is shown in the Figure 2, there 
are several methods to assign a cutoff for identification 
of the important nodes. In some cases mean +2 standard 
deviation or top 5% of the nodes are selected as important 
nodes and also the top nodes that deviated from power 
law are introduced as the key nodes (Safari-Alighiarloo et 
al., 2016; Zamanian-Azodi et al., 2015; Safari-Alighiarloo 
et al., 2017). Based on distribution of degree value the 
vital hub nodes can be specified. The power law of 
this distribution implies 40 is a suitable cutoff (see the 
Figure 2). Similarly, betweenness distribution can be used 
to define bottleneck nodes . The betweenness value (0.02) 
is a critical value in the Figure 2. Closeness distribution 
indicates that 0.5 is the starting point of deviation from 
power law (see Figure 2). As it was described the three 
proteins including TP53, EGFR and AKT1 are the 
super-hub proteins. The all hub nodes except CDKN2A 
are bottleneck nodes. Closeness centrality analysis showed 
that the top eight nodes are essential nodes. Since degree 
distribution (Figure 2) provided the limited information 
about the hub nodes, the degree values were classified in 
four groups (see Figure 3). The top three groups including 
eight nodes correspond to closeness distribution indicate 
that the top eight nodes in the Table 1 are the potent hub 
proteins. As it is shown in the Table 1, the first eight nodes 
are characterized by the higher betweenness values in 
compare to the other nodes. It can be concluded that, the 
first eight nodes in Table 1 including TP53, EGFR, AKT1, 
ERBB2, MYC, CCND1, CTNNB1 and BCL2L1, are a 
suitable candidate biomarker panel related to esophageal 
adenocarcinoma disease; yet, more analysis is needed to 
support this claim. 
A dense part of a network including some nodes 
that are closely connected together is called cluster 
(Milenkovic and Przulj, 2008). The elements of a cluster 
participate in a closed biological function and processes 
(Ashburner et al., 2000). The main cluster of the network 
(Figure 4) provided novel information. Analysis of this 
sub-network leads to introduce some important proteins. 
Based on degree value of the 27 nodes of cluster network, 
it is possible that the proteins to be categorized in five 
groups (see Figure 5). As it is shown in the Figure 5, 
the top two groups include 10 hub nodes of the cluster. 
The central parameters of these 10 hub nodes of cluster 
network are tabulated in Table 2. Comparison of Tables 1 
and 2 is a useful tool for better understanding of the role 
of the agents of Table 1. In the first glance, it is depicted 
that the eight key proteins in Table 1, are presented in 
Table 2 and the more information is shown in Table 3. 
The second point is presence of the ninth node of Table 1 
in the eighth row of Table 2. It seems that considering 
the role of BCL2L1 in cluster-1, implies that it can be 
added to the elements of the introduced biomarker panel. 
In a transcriptome study, two genes including SPARC 
and SPP1 were introduced as prognostic biomarkers 
for EAC ( Kim et al., 2010), but these proteins are not 
included in our panel. However there are documents 
that indicate to the regulatory role of SPARC on TP53 
inactivation via AKT mediated process (Fenouille et al., 
Figure 7. Gene Ontology by Using ClueGO for 27 
Proteins of Cluster-1 is Presented. The selected terms 
were limited to the terms that at least were included 
5 initial proteins and 3% Proteins/Term. .Kappa score 
(Term/Pathway connectivity) was 0.2. The bars that 
are labeled by numbers corresponded to the attributed 
proteins in terms. The terms are categorized in three 
groups (the groups are shown in the three colors).
Figure 8. The Identified Terms in Figure 7, are Classified 
in Three Groups. Frequencies of the member of colorectal 
cancer, bladder cancer and regulation of G1/S transition 
of mitotic cell cycle groups are 72%, 18.5% and 9.5% 
respectively. 
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2011). In the other report regulation of SPP1-PI3K-AKT 
signaling pathway in cancer is emphasized (Yang et al., 
2012). The assessed patients are mainly (above 50%) 
men and are in stages II and III. These conditions may 
affect the expression of the studied proteins. Expression 
change of EGFR and ERBB2 in EAC patients is reported 
by (Al-Kasspooles et al., 1993). The prominent role of 
TP53 in cancer and EAC is discussed in several studies 
(Wang et al., 1993; Verma et al., 2016). Relationship 
between MYC, AKT1, CTNNB1, CDH, BCL2L1, and 
CCND1 proteins is investigated and emphasized (Carneiro 
et al., 2008; Essack, 2009). The main role of TP53 in 
early event of esophagus cancer is confirmed by (Gao et 
al., 1994). Amplification of c-myc, EGFR and the 20q12 
loci related to early event of esophagus cancer that are 
detectable by using FISH on brush cytology specimens 
is reported by previously (Lu et al., 1988). The role of 
AKT signaling pathway in chemoresistance induction in 
esophageal cancers is reported and discussed in details 
(Hamano et al., 2011; Hildebrandt et al., (2009). It seems 
that a biomarker panel including TP53, EGFR, and 
AKT1 can be used as diagnostic agent in early stage of 
esophagus cancer. It is reasonable idea that the amount 
of expression change of these genes in correlation with 
development of disease be increased. Genomic study 
of oesophageal carcinoma showed expression change 
of CCND1 in squamous cell carcinomas, whereas 
ERBB2 amplified in adenocarcinomas (Network, (2017). 
Comparative analysis of the Tables 1 and 2, expresses 
that the identified cluster is the core part of the network 
of esophageal adenocarcinoma. Closed connections 
between the nine key proteins are shown in Figure 6. Each 
protein is connected to the other eight proteins. Since the 
all-key nodes are common between the main network 
and cluster-1, gene ontology of the elements of cluste-1 
can provide useful information about related biological 
processes to EAC. Gene ontology finding indicated 
that, the nodes of cluster-1 play fundamental roles in 
esophageal adenocarcinoma malignancy. The identified 
terms (see Figures 7-8) are related closely to the cancer 
especially colorectal cancers. It is a potent confirmation 
for the findings of the analyzed network. Therefore, it is a 
novel combination and ranked gene set that is introduced 
as biomarker panel of EAC. 
In conclusion, it can be concluded that, there is 
a cluster including 27 proteins related to esophageal 
adenocarcinoma disease. By consider the elements of 
cluster-1 and the key proteins in the PPI network of this 
disease, a panel including TP53, EGFR, AKT1, ERBB2, 
MYC, CCND1, CTNNB1, CDH1, AND BCL2L1 was 
introduced as a candidate biomarker panel for esophageal 
adenocarcinoma. Still, more investigation in the field is 
required for validation of these findings. 
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